Date: July 23
Time: 2 p.m. EDT/6 p.m. UTC
Pulmonary hypertension treatments continue to evolve, offering new ways to help people feel better, stay active and improve their overall quality of life. One advancing treatment option is inhaled therapy which delivers medication directly to the lungs.
Join the Pulmonary Hypertension Association and PHA Europe for “Inhaled Therapies for Pulmonary Hypertension: Where We Are and What’s Next.”
The webinar speakers will discuss the current landscape and future of inhaled therapies in PH, including:
- Currently approved inhaled therapies for PH.
- Key differences between inhaled treatment options and the conditions they manage, including PH-ILD.
- New and emerging therapies being studied in clinical trials.
- Practical information about safely managing and using inhaled therapies.
Whether you are newly diagnosed, currently using inhaled therapy or simply interested in learning about future treatment possibilities, this webinar will help you better understand your care options.
The webinar will be available in English and Spanish.
Speakers
Heidi Miller APRN, FNP-C, CHFN
Nurse practitioner, Advanced Heart Failure and Pulmonary Hypertension Program
Supervisor, Heart Recovery and Transplant Center
Baylor St. Luke’s Medical Center
Elizabeth Quintero, MSN, AGNP- BC
Pulmonary Hypertension Advanced Gerontology nurse practitioner
AdventHealth Orlando Florida
Cyrus Vahdatpour, MD
Assistant Professor
Baylor College of Medicine
Advanced Lung Disease
